Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) EBT: 2018-2019

Historic EBT for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to -$2.5 million.

  • DiaMedica Therapeutics' EBT fell 26.69% to -$2.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$10.6 million, marking a year-over-year decrease of 87.80%. This contributed to the annual value of -$24.4 million for FY2024, which is 26.25% down from last year.
  • According to the latest figures from Q4 2019, DiaMedica Therapeutics' EBT is -$2.5 million, which was down 1.72% from -$2.4 million recorded in Q3 2019.
  • DiaMedica Therapeutics' EBT's 5-year high stood at -$649,000 during Q1 2018, with a 5-year trough of -$3.2 million in Q1 2019.
  • Moreover, its 2-year median value for EBT was -$2.2 million (2018), whereas its average is -$2.0 million.
  • Data for DiaMedica Therapeutics' EBT shows a maximum YoY crashed of 399.69% (in 2019) over the last 5 years.
  • Over the past 2 years, DiaMedica Therapeutics' EBT (Quarterly) stood at -$2.0 million in 2018, then fell by 26.69% to -$2.5 million in 2019.
  • Its EBT was -$2.5 million in Q4 2019, compared to -$2.4 million in Q3 2019 and -$2.5 million in Q2 2019.